UroGen Pharma Ltd.
NASDAQ:URGN
12.12 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -102.244 | -109.783 | -110.82 | -128.484 | -105.146 | -75.657 | -20 | -1.941 | -12.689 | -4.476 | -3.306 |
| Depreciation & Amortization
| 1.705 | 1.817 | 1.773 | 2.044 | 1.324 | 0.417 | 0.207 | 0.213 | 0.113 | 0.03 | 0.018 |
| Deferred Income Tax
| -0.068 | 0 | 15.324 | 0.439 | -0.572 | 0 | 0 | 0 | 0.24 | 0 | 0 |
| Stock Based Compensation
| 9.344 | 10.58 | 23.113 | 28.025 | 29.967 | 30.642 | 6.3 | 1.967 | 0.449 | 0.293 | 0.541 |
| Change In Working Capital
| 3.336 | -6.306 | -13.106 | -6.369 | 4.32 | 7.164 | 3.757 | 1.21 | 0.609 | -0.162 | 0.013 |
| Accounts Receivables
| -2.739 | -0.987 | -4.671 | -7.047 | 0 | 3.293 | 0.083 | -0.083 | 0 | 0 | 0 |
| Inventory
| -1.348 | -0.362 | -2.868 | -1.964 | 0 | 0.316 | -0.211 | -0.105 | 0 | 0 | 0 |
| Accounts Payables
| 4.155 | 0.281 | 1.998 | -1.245 | 2.928 | 4.205 | 2.534 | 0.481 | 1.155 | 0 | 0 |
| Other Working Capital
| 3.268 | -5.238 | -7.565 | 3.887 | 1.392 | -0.65 | 1.351 | 0.917 | -0.546 | -0.162 | 0.013 |
| Other Non Cash Items
| 11.552 | 16.133 | -1.176 | -1.541 | -0.91 | 0.1 | 0.165 | 2.74 | 4.103 | 0.198 | 0.177 |
| Operating Cash Flow
| -76.376 | -87.559 | -84.892 | -105.886 | -71.017 | -37.334 | -9.571 | 4.189 | -7.175 | -4.117 | -2.557 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0.194 | -0.254 | -0.752 | -1.215 | -0.325 | -0.56 | -0.271 | -0.695 | -0.301 | -0.024 | -0.057 |
| Acquisitions Net
| 0.759 | -1.314 | -4.821 | -94.453 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -49.832 | -63.009 | -51.898 | -29.688 | -197.686 | -0.054 | -36.001 | -0.024 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 49.073 | 64.323 | 56.719 | 124.141 | 52.59 | 35.901 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.759 | 1.314 | 4.821 | 94.453 | -0.172 | -0.054 | -0.105 | -0.098 | 0 | 0.023 | -0.032 |
| Investing Cash Flow
| -0.953 | 1.06 | 4.069 | 93.238 | -145.593 | 35.287 | -36.377 | -0.793 | -0.301 | -0.001 | -0.089 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | -95.783 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.647 | 0 |
| Common Stock Issued
| 116.931 | 1.351 | -0.083 | 15.853 | 165.25 | 64.235 | 60.841 | -0.009 | 21.581 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 116.931 | 1.351 | 72.402 | 0.674 | 165.25 | 2.186 | 0.744 | -0.009 | 21.581 | 4.304 | 3.468 |
| Financing Cash Flow
| 116.931 | 97.134 | 72.319 | 16.527 | 165.25 | 66.421 | 61.585 | -0.009 | 21.581 | 4.951 | 3.468 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 39.602 | 10.635 | -8.504 | 3.879 | -51.36 | 64.374 | 15.637 | 3.387 | 14.105 | 0.833 | 0.822 |
| Cash At End Of Period
| 95.823 | 56.221 | 45.586 | 54.09 | 50.211 | 101.571 | 36.999 | 21.362 | 17.975 | 3.87 | 3.037 |